Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Parmax Pharma Ltd

NSE: PARMAX · BSE: 540359 · Pharmaceuticals & Biotechnology · 29 announcements

Share price
₹139.10
Market cap
₹52.04 Cr
Revenue (annual)
₹12.11 Cr
Net profit (annual)
₹-4.16 Cr
P/E (TTM)
-43.5×Sector 47.4×
Promoter holding
64.66%+33.86% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

22:10 IST BSE
Management Change

Parmax Pharma Management Change

Parmax Pharma Limited announced the appointment of Dhiren Shah and Sunil Shah as Directors. Additionally, Ms. Salma Thobhani resigned as a Non-Executive Non-Independent Director.

17:59 IST BSE
Management Change

Parmax Pharma Management Change

Parmax Pharma Ltd has approved the re-appointment of Dr. Umang Gosalia (DIN: 05153830) as Managing Director for a five-year term starting June 28, 2026. Dr. Gosalia, associated with the firm since 2016, oversees production activities. The appointment is subject to shareholder approval at the upcoming general meeting.

Execution
5 years